Exploring the MicroRNA Landscape in Cardiac Amyloidosis: Molecular Insights and Clinical Applications
MiRNAs represent promising diagnostic and prognostic biomarkers in cardiac amyloidosis and offer mechanistic insights into disease pathogenesis. Integration of miRNA profiling with multimodality imaging and emerging RNA-based therapeutics may enable earlier diagnosis and support precision management of amyloid-related heart failure.
Authors
- E. M. Kallergis
- Joanna Kontaraki (ORCID: https://orcid.org/0000-0003-3160-1856)
- Evangelos Zacharis
- Maria E. Marketou (ORCID: https://orcid.org/0000-0003-1888-3430)
- Konstantinos Fragkiadakis (ORCID: https://orcid.org/0000-0002-5342-5411)
- Emmanouil Kampanieris
- Emmanouil Simantirakis
- Aleksi Sallo
- Sophia Achladianaki
- Vasiliki Papakosta
- John Kopidakis
- Anthoula Plevritaki
Institutions
- University of Crete (GR)
- University Hospital of Heraklion (GR)
Publication Details
- Journal
- Genes
- Published
- 2026-03-23
- DOI
- https://doi.org/10.3390/genes17030356
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00